Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ovarian Cancer
Clinical trial register · Belgium

Ovarian Cancer Trials in Belgium, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Leuven 21 Ghent 13 Brussels 12 Liège 8 Namur 5

Ovarian Cancer trials in Belgium

27 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Not yet open
AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery
NCT07883551Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor
Catharina Ziekenhuis Eindhoven
Observational
1,300
Ghent
2026-11
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
NCT07902375Gynaecological Cancers, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer
Universiteit Antwerpen
Not applicable
730
Edegem
2026-06-19
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Brussels, Edegem, Leuven
2026-04-17
Recruiting
Gilead Sciences
Phase 1/2
72
Brussels, Ghent, Leuven, Liège
2026-03-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Charleroi, Ghent, Leuven
2026-02-16
Recruiting
Incyte Corporation
Phase 3
466
Brussels, Ghent, Kortrijk, Leuven
2025-12-09
Recruiting
Incyte Corporation
Phase 2
160
Brussels, Kortrijk, Leuven, Liège
2025-11-12
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT06906341Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms, Endometrial Cancer
Corcept Therapeutics
Phase 2
270
Aalst, Charleroi, Hasselt, Leuven
2025-04-11
Recruiting
Daiichi Sankyo
Phase 3
582
Ghent, Leuven, Liège, Namur, Woluwe-Saint-Lambert
2025-03-19
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Brussels, Ghent, Hasselt, Leuven
2024-10-11
Recruiting
Gilead Sciences
Phase 1/2
334
Leuven
2024-06-12
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
NCT06276491Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor
Xencor, Inc.
Phase 1
282
Kortrijk, Leuven, Liège
2024-04-04
Active, closed
AbbVie
Phase 3
520
Bonheiden, Brussels, Charleroi, Ghent, Leuven, Roeselare, Namur
2023-03-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Brussels, Ghent, Leuven, Kortrijk
2021-12-13
Recruiting
AstraZeneca
Phase 1/2
460
Anderlecht, Leuven
2021-10-18
Active, closed
Pfizer
Phase 3
77
Ghent, Gilly
2021-09-29
Active, closed
Verastem, Inc.
Phase 2
225
Ghent, Leuven, Liège
2020-12-21
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
612
Leuven
2020-12-08
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
CanariaBio Inc.
Phase 3
615
Antwerp, Brussels, Liège
2020-08-25
Active, closed
AstraZeneca
Phase 3
185
Leuven
2020-08-04
Active, closed
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
BicycleTx Limited
Phase 1/2
288
Brussels, Edegem, Ghent
2019-11-07
Active, closed
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
NCT03842982Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
DrugHipec
Centre Oscar Lambret
Phase 3
362
Brussels
2019-05-03
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-belgium/condition/ovarian-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies listing the condition Ovarian Cancer.

How many Ovarian Cancer trials are recruiting in Belgium?

17 of the 27 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ovarian Cancer), 27 studies
PhaseStudiesRecruitingShare
Phase 312644.4%
Phase 27525.9%
Phase 1/25418.5%
Not applicable113.7%
Observational103.7%
Phase 1113.7%

Most active sponsors

Lead sponsors with the most studies (Ovarian Cancer)
Lead sponsorStudiesRecruiting
AstraZeneca31
Merck Sharp & Dohme LLC32
AbbVie21
Gilead Sciences22
Incyte Corporation22
BicycleTx Limited10
CanariaBio Inc.10
Catharina Ziekenhuis Eindhoven10
Centre Oscar Lambret10
Corcept Therapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.